Benchmark Ultra
Payments companies reported to CMS as associated with Benchmark Ultra. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Benchmark Ultra, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Benchmark Ultra
These are the largest totals companies reported as associated with Benchmark Ultra. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Drazen Jukic | Savannah, GA | Dermatopathology (Pathology) | $3,086.69 |
| Magdalena Czader | Indianapolis, IN | Clinical Pathology/Laboratory Medicine | $2,258.17 |
| Michael Feldman | Indianapolis, IN | Anatomic Pathology & Clinical Pathology | $1,703.49 |
| Chirag Patel | Scottsdale, AZ | Clinical Pathology/Laboratory Medicine | $1,388.42 |
| Elba Torres Matundan | San Juan, PR | Anatomic Pathology & Clinical Pathology | $1,055.47 |
| Rosa Cortes Rivera | San Juan, PR | Anatomic Pathology & Clinical Pathology | $830.73 |
| Kelly Hall | Fort Sam Houston, TX | Dermatopathology (Pathology) | $474.14 |
| Nathan Teschan | San Antonio, TX | Anatomic Pathology & Clinical Pathology | $460.03 |
| Yorke Young | Knoxville, TN | Anatomic Pathology & Clinical Pathology | $329.91 |
| Frank Sinicrope | Rochester, MN | Medical Oncology | $267.21 |
Prescribed Benchmark Ultra?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.